3,4-Dichloromethylphenidate
A stimulant drug related to methylphenidate
| 3,4-Dichloromethylphenidate | |
|---|---|
|
|
3,4-Dichloromethylphenidate (3,4-DCMP) is a stimulant drug that is chemically related to methylphenidate. It is known for its effects on the central nervous system and is used in research settings to study its pharmacological properties.
Chemical structure and properties[edit]
3,4-Dichloromethylphenidate is a derivative of methylphenidate, with two chlorine atoms substituted at the 3 and 4 positions of the phenyl ring. This modification alters its pharmacokinetic and pharmacodynamic properties compared to methylphenidate.
Pharmacology[edit]
3,4-DCMP acts primarily as a dopamine reuptake inhibitor, similar to methylphenidate. This action increases the concentration of dopamine in the synaptic cleft, leading to enhanced dopaminergic neurotransmission. The presence of chlorine atoms in its structure may affect its binding affinity and selectivity for dopamine transporters.
Uses[edit]
While 3,4-DCMP is not approved for medical use, it is utilized in scientific research to explore its potential effects on the brain and behavior. Studies may investigate its impact on attention, memory, and cognitive function.
Safety and legal status[edit]
As a research chemical, 3,4-DCMP is not regulated in the same manner as prescription medications. However, its legal status may vary by country, and it is important for researchers to comply with local regulations when handling this compound.
Related compounds[edit]
See also[edit]
Related pages[edit]
3,4-Dichloromethylphenidate[edit]
-
3,4-Dichloromethylphenidate
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian